• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期肾病患者中白细胞介素-17 产生的效应记忆 T 细胞增加。

Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients.

机构信息

Conversant Research Consorcium in Immunologic Disease, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

出版信息

Immunol Lett. 2012 Jan 30;141(2):181-9. doi: 10.1016/j.imlet.2011.10.002. Epub 2011 Oct 8.

DOI:10.1016/j.imlet.2011.10.002
PMID:22004873
Abstract

Patients with end-stage renal disease (ESRD) exhibit immune dysregulation, but the precise immunological profile and the effect of hemodialysis (HD) on it has not been investigated fully. Thirty-eight ESRD patients (22 on HD and 16 in pre-dialysis) and 24 healthy volunteers were included. We compared the T cell immune profiles as in these patients. Among the effector T cell subset, the percentages of Th17 and Th2 cells were significantly higher in the ESRD group than in the healthy controls (P<0.05). The percentage of Th1 cells did not differ significantly between these groups. The percentages of Th1, Th2 and Th17 cells did not differ significantly (P>0.05) between the two subgroups within the ESRD group. The CCR4(-)CCR6(+)/CD4(+) T cell percentage was also significantly higher in the ESRD group. The naïve T cell (T(naïve)) percentage was significantly lower in the ESRD group, and the difference between patients and controls was greater in the pre-dialysis patients than in the HD patients (P<0.05, for each comparison). By contrast, the percentages of central memory T cells (T(CM)) and effector memory T (T(EM)) cells were significantly higher in the ESRD group. Interleukin-17 production by T(EM) cells was significantly higher in the ESRD group. The severity of uremia was related negatively to the T(naïve) cell percentage but positively to the T(CM) and T(EM) cell percentages. The percentages of T(EM) and CD45RA(+) T effector memory subsets of CD8(+) T cells were significantly higher in the ESRD group (P<0.05). The result of this study showed significantly altered T cell-associated immunity and that it could not be corrected with hemodialysis.

摘要

终末期肾病(ESRD)患者表现出免疫失调,但尚未充分研究其确切的免疫学特征和血液透析(HD)的影响。纳入 38 例 ESRD 患者(22 例接受 HD,16 例在透析前)和 24 名健康志愿者。我们比较了这些患者的 T 细胞免疫特征。在效应 T 细胞亚群中,ESRD 组 Th17 和 Th2 细胞的百分比明显高于健康对照组(P<0.05)。两组间 Th1 细胞的百分比无显著差异。ESRD 组内两个亚组间 Th1、Th2 和 Th17 细胞的百分比无显著差异(P>0.05)。ESRD 组 CCR4(-)CCR6(+)/CD4(+)T 细胞的百分比也明显更高。ESRD 组的幼稚 T 细胞(T(naïve))百分比明显较低,且在透析前患者中与对照组的差异大于 HD 患者(P<0.05,每一次比较)。相反,中央记忆 T 细胞(T(CM))和效应记忆 T(T(EM))细胞的百分比在 ESRD 组明显较高。T(EM)细胞产生的白细胞介素-17 在 ESRD 组明显较高。尿毒症的严重程度与 T(naïve)细胞百分比呈负相关,与 T(CM)和 T(EM)细胞百分比呈正相关。ESRD 组 T(EM)和 CD45RA(+)T 效应记忆细胞亚群的 CD8(+)T 细胞百分比明显较高(P<0.05)。本研究结果显示 T 细胞相关免疫明显改变,血液透析无法纠正。

相似文献

1
Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients.终末期肾病患者中白细胞介素-17 产生的效应记忆 T 细胞增加。
Immunol Lett. 2012 Jan 30;141(2):181-9. doi: 10.1016/j.imlet.2011.10.002. Epub 2011 Oct 8.
2
Naïve and central memory T-cell lymphopenia in end-stage renal disease.终末期肾病中的初始和中枢记忆性T细胞淋巴细胞减少症。
Kidney Int. 2006 Jul;70(2):371-6. doi: 10.1038/sj.ki.5001550. Epub 2006 May 31.
3
Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients.尿毒症患者中辅助性T淋巴细胞向Th2表型极化。
Am J Kidney Dis. 2001 Aug;38(2):286-95. doi: 10.1053/ajkd.2001.26092.
4
Coexpression of CCR6 and CD146 (MCAM) is a marker of effector memory T-helper 17 cells.CCR6 和 CD146(MCAM)的共表达是效应记忆 T 辅助 17 细胞的标志物。
J Dermatol. 2012 Oct;39(10):838-42. doi: 10.1111/j.1346-8138.2012.01544.x. Epub 2012 Apr 5.
5
Electrolysed-reduced water dialysate improves T-cell damage in end-stage renal disease patients with chronic haemodialysis.电解还原水透析液可改善慢性血液透析终末期肾病患者的 T 细胞损伤。
Nephrol Dial Transplant. 2010 Aug;25(8):2730-7. doi: 10.1093/ndt/gfq082. Epub 2010 Feb 26.
6
Abnormal cytokine synthesis as a consequence of increased intracellular oxidative stress in children treated with dialysis.接受透析治疗的儿童因细胞内氧化应激增加而导致细胞因子合成异常。
Nephron Clin Pract. 2005;101(2):c100-8. doi: 10.1159/000086348. Epub 2005 Jun 14.
7
Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.通过流式细胞术分析类风湿关节炎中表达CD4 +和CD8 + T细胞的Th1和Th2细胞因子
J Rheumatol. 2000 May;27(5):1128-35.
8
An altered TH1/TH2 and pro-inflammatory cytokine profile in patients with end-stage renal disease detected by suspension array technology.通过悬浮阵列技术检测到终末期肾病患者中TH1/TH2和促炎细胞因子谱的改变。
Ren Fail. 2009;31(1):1-5. doi: 10.1080/08860220802516449.
9
The difference of T cell phenotypes in end stage renal disease patients under different dialysis modality.不同透析方式的终末期肾病患者 T 细胞表型的差异。
BMC Nephrol. 2019 Aug 5;20(1):301. doi: 10.1186/s12882-019-1475-y.
10
Inflammatory, degenerative and vascular lesions in long-term dialysed patients.长期透析患者的炎症、退行性变及血管病变
Rom J Intern Med. 2009;47(2):149-59.

引用本文的文献

1
Lower absolute numbers of CD4 naïve and CD8 effector memory cells in peripheral blood are potential predictive indicators of renal endpoint events in patients with chronic kidney disease.外周血中初始CD4细胞和CD8效应记忆细胞的绝对数量较低是慢性肾病患者肾脏终点事件的潜在预测指标。
Ren Fail. 2025 Dec;47(1):2552914. doi: 10.1080/0886022X.2025.2552914. Epub 2025 Aug 31.
2
Immunomodulatory effect of CD71 erythroid cells in patients with kidney failure.CD71 红系细胞对肾衰竭患者的免疫调节作用。
BMC Nephrol. 2025 Aug 6;26(1):439. doi: 10.1186/s12882-025-04376-w.
3
Uncovering Candidate Genes Associated with Cardiovascular Disease in Patients with Arteriovenous Fistula and End-Stage Renal Disease.
揭示动静脉内瘘和终末期肾病患者中与心血管疾病相关的候选基因。
Cardiorenal Med. 2025;15(1):386-398. doi: 10.1159/000546299. Epub 2025 May 7.
4
Systematic review and quantitative meta-analysis of age-dependent human T-lymphocyte homeostasis.年龄依赖性人类T淋巴细胞稳态的系统评价与定量荟萃分析。
Front Immunol. 2025 Jan 27;16:1475871. doi: 10.3389/fimmu.2025.1475871. eCollection 2025.
5
T-Cell Subpopulations and Differentiation Bias in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease.糖尿病和非糖尿病慢性肾脏病患者的T细胞亚群及分化偏向
Biomedicines. 2024 Dec 24;13(1):3. doi: 10.3390/biomedicines13010003.
6
TH1 Cell Frequency and Neutrophil-to-Lymphocyte Ratio in Hemodialysis: Potential Contributions to Patient Monitoring.血液透析中TH1细胞频率与中性粒细胞与淋巴细胞比值:对患者监测的潜在贡献
Biomedicines. 2024 Sep 26;12(10):2188. doi: 10.3390/biomedicines12102188.
7
IL-17A Levels and Progression of Kidney Disease Following Hospitalization with and without Acute Kidney Injury.住院后伴或不伴急性肾损伤情况下的白细胞介素-17A水平与肾脏疾病进展
Kidney360. 2024 Nov 1;5(11):1623-1632. doi: 10.34067/KID.0000000000000559. Epub 2024 Sep 4.
8
Generalized Pustular Psoriasis and Systemic Organ Dysfunctions.泛发性脓疱型银屑病并系统器官功能障碍。
Int J Mol Sci. 2024 Jun 6;25(11):6270. doi: 10.3390/ijms25116270.
9
Development and validation of the prediction model for mortality in patients with diabetic kidney disease in intensive care unit: a study based on medical information Mart for intensive care.基于重症监护医疗信息集市的重症监护病房糖尿病肾病患者死亡率预测模型的建立与验证研究。
Ren Fail. 2023;45(2):2257808. doi: 10.1080/0886022X.2023.2257808. Epub 2023 Sep 19.
10
Association of psoriasis with chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis.银屑病与慢性肾脏病及终末期肾病的关联:一项系统综述与荟萃分析
Front Med (Lausanne). 2023 May 12;10:1175477. doi: 10.3389/fmed.2023.1175477. eCollection 2023.